Propanc Biopharma, Inc. (Nasdaq: PPCB) ('Propanc” or the 'Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, ...

We don't know the history of this royal piece but she's reaching for it more often - and it brings a contemporary edge to her ...

Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...

Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S. Food and Drug Administration (FDA) with ...

A Portland State University-led research team has developed a novel chemical compound that shows promise for the treatment ...

Alexx Ekubo (1986–2026) was not just a screen idol but a law graduate and humanitarian whose impact spanned over two decades in the creative industry. Alexx Ekubo will be remembered not only for his ...

Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery and developmentManufacturing divestiture and expanded monetization of ZYNYZ royalty anticipated to prov ...

A global expert panel has recently announced that polycystic ovary syndrome (PCOS) will officially undergo a name change to ...